Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs.
D000818:Animals; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004285:Dogs; D006914:Hydroxysteroids / Q000627:therapeutic use; D007664:Ketosteroids / Q000008:administration & dosage / Q000627:therapeutic use; D010042:Ouabain / Q000037:antagonists & inhibitors; D011189:Potassium Chloride / Q000494:pharmacology; D011245:Pregnadienes / Q000008:administration & dosage / Q000627:therapeutic use*; D011422:Propionates / Q000008:administration & dosage / Q000627:therapeutic use; D013148:Spironolactone / Q000494:pharmacology; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy*
D004071:Digitalis Glycosides; D006914:Hydroxysteroids; D007664:Ketosteroids; D011245:Pregnadienes; D011422:Propionates; D013148:Spironolactone; D010042:Ouabain; D011189:Potassium Chloride